Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Medicine and Science in Sports and Exercise|December 24, 2015
Effects of an Exercise Program in Colon Cancer Patients undergoing ChemotherapyJonna K Van Vulpen, Miranda J Velthuis, Charlotte N Steins Bisschop, et al.
The New England Journal of Medicine|February 7, 2009
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancerJolien Tol, Miriam Koopman, Annemieke Cats, et al.
JNCI Cancer Spectrum|November 22, 2023
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancerSenna W M Lammers, Sandra M E Geurts, Irene E G van Hellemond, et al.
Clinical Breast Cancer|May 17, 2011
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trialPaul Hamberg, Monique M E M Bos, Hans J J Braun, et al.
Cancer Medicine|December 19, 2019
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trialSophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
The Lancet. Oncology|October 17, 2017
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C G Tjan-Heijnen, Irene E G van Hellemond, Petronella G M Peer, et al.
The Lancet Regional Health. Europe|March 10, 2023
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE RegistryMarissa Meegdes, Sandra M E Geurts, Frans L G Erdkamp, et al.
International Journal of Cancer|February 13, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA studyIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
Breast Cancer Research and Treatment|March 4, 2020
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trialIrene E G van Hellemond, Carolien H Smorenburg, Petronella G M Peer, et al.
Breast Cancer Research and Treatment|October 25, 2023
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registrySenna W M Lammers, Hannah Thurisch, Ingeborg J H Vriens, et al.
Pageof 3